Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients

Abstract EN

Matrix Metalloproteases (MMPs) and cytokines have been involved in the pathogenesis of multiple sclerosis (MS).

However, no studies have still explored the possible associations between the two families of molecules.

The present study aimed to evaluate the contribution of active MMP-9, active MMP-2, interleukin- (IL-) 17, IL-18, IL-23, and monocyte chemotactic proteins-3 to the pathogenesis of MS and the possible interconnections between MMPs and cytokines.

The proteins were determined in the serum and cerebrospinal fluid (CSF) of 89 MS patients and 92 other neurological disorders (OND) controls.

Serum active MMP-9 was increased in MS patients and OND controls compared to healthy subjects ( p < 0.001 and p < 0.01 , resp.), whereas active MMP-2 and ILs did not change.

CSF MMP-9, but not MMP-2 or ILs, was selectively elevated in MS compared to OND ( p < 0.01 ).

Regarding the MMPs and cytokines intercorrelations, we found a significant association between CSF active MMP-2 and IL-18 ( r = 0.3 , p < 0.05 ), while MMP-9 did not show any associations with the cytokines examined.

Collectively, our results suggest that active MMP-9, but not ILs, might be a surrogate marker for MS.

In addition, interleukins and MMPs might synergistically cooperate in MS, indicating them as potential partners in the disease process.